Antiviral activity was observed at all dose levels tested either as single agent or in combination with ribavirin. Treatment was well-tolerated with reversible, dose-dependent increases in liver enzyme
In this 15-day study, SCY-635 was well-tolerated with no serious adverse events, no discontinuations and no dose-limiting toxicities. At the highest dose tested in the study (900mg/day) SCY-635
Mr Mitchell is chairman of the board and CEO of Arrow Electronics, a provider of products, services and solutions to industrial and commercial users of electronic components and
Poniard Pharmaceuticals has reported encouraging data from a Phase I dose-escalation study of picoplatin in patients with metastatic colorectal cancer. Results demonstrated that picoplatin can be safely administered
Genesis Pharmaceuticals Enterprises, a US-based pharmaceutical company with its principal operations in China, has launched three traditional Chinese medicines. The traditional Chinese medicines (TCMs) are Yi Mu Cao
The measures are expected to generate increased operational efficiencies and reduce costs while continuing to allow Sequenom to serve the needs of its current and future genetic analysis
The trial was sponsored by the National Cancer Institute (NCI) and led by the Eastern Cooperative Oncology Group under a clinical trials agreement between NCI and Bayer and
According to the company, the job cuts are expected to be completed by June 22, 2009. Arena believes that job reduction is necessary to reduce its cash usage
Dr Pardoll is an active member of the National Association of Healthcare Consultants and the founding past managing partner of the Center for Digestive Diseases in St Petersburg,
The Eurtac trial is the first prospective, randomized Phase III trial to investigate whether first line treatment with Tarceva is superior to chemotherapy in patients with epidermal growth
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.